Key result
The HEART multicomponent home care intervention significantly improved quality of life (P=0.007) and reduced depressive symptoms (P=0.001), with 90-day readmission rates of 16% vs 25%.
Why the study?
Does a nurse-directed multicomponent home care intervention improve quality of life, depressive symptoms, and hospitalization rates in older adults with heart failure?
Does a nurse-directed multicomponent home care intervention improve quality of life, depressive symptoms, and hospitalization rates in older adults with heart failure?
A nurse-directed multicomponent home care intervention is feasible and significantly improves quality of life and depressive symptoms in older adults with heart failure.
In Brief Background: Heart failure (HF) has clinically significant psychological and physical consequences for older persons, and hospitalization for HF is frequent and costly to the Medicare program. As HF is the most common primary Medicare home care diagnosis, there is a critical need to develop home care services that improve heath-related outcomes for this population. The primary aim of this pilot study was to develop, implement, and test the initial feasibility and potential efficacy of the Home-Care Education, Assessment, Remote-Monitoring, and Therapeutic Activities (HEART) trial, a nurse-directed multicomponent home care intervention. Observed outcomes were quality of life (QOL), depressive symptoms, and 90-day hospitalization. Methods: Twenty-four patients with a primary diagnosis of HF were assigned to the intervention (n = 12) or control group (n = 12) according to geographical location in a large multibranch Medicare-certified home health agency. Intervention group patients received 8 structured nurse education visits using evidence-based protocols designed in previous trials to teach HF self-management and to prevent/reduce depression, as well as a telemonitoring system. Control group patients received usual care and telemonitoring. Quality of life was assessed using the Minnesota Living With Heart Failure questionnaire. Depressive symptoms were assed using the Patient Health Questionnaire 9 at baseline and 90-day study end point. Results: Study protocols and instrumentation were found to be feasible and effective. Examination of enrollment data led to a reevaluation of eligibility criteria. Patients participating in the HEART intervention demonstrated significantly improved QOL (F = 8.99, P = .007) and significantly reduced depressive symptoms (F = 35.10, P = .001) in comparison to control group patients at the study end point. There was a trend toward lower hospital readmission rates in the intervention group (16% vs 25%), but this was not statistically significant. Conclusion: This pilot study suggests that a full-scale trial of the HEART intervention is feasible. Background: Heart failure (HF) has clinically significant psychological and physical consequences for older persons, and hospitalization for HF is frequent and costly to the Medicare program. As HF is the most common primary Medicare home care diagnosis, there is a critical need to develop home care services that improve heath-related outcomes for this population. The primary aim of this pilot study was to develop, implement, and test the initial feasibility and potential efficacy of the Home-Care Education, Assessment, Remote-Monitoring, and Therapeutic Activities (HEART) trial, a nurse-directed multicomponent home care intervention. Observed outcomes were quality of life (QOL), depressive symptoms, and 90-day hospitalization. Methods: Twenty-four patients with a primary diagnosis of HF were assigned to the intervention (n = 12) or control group (n = 12) according to geographical location in a large multibranch Medicare-certified home health agency. Intervention group patients received 8 structured nurse education visits using evidence-based protocols designed in previous trials to teach HF self-management and to prevent/reduce depression, as well as a telemonitoring system. Control group patients received usual care and telemonitoring. Quality of life was assessed using the Minnesota Living With Heart Failure questionnaire. Depressive symptoms were assed using the Patient Health Questionnaire 9 at baseline and 90-day study end point. Results: Study protocols and instrumentation were found to be feasible and effective. Examination of enrollment data led to a reevaluation of eligibility criteria. Patients participating in the HEART intervention demonstrated significantly improved QOL (F = 8.99, P = .007) and significantly reduced depressive symptoms ((F = 35.10, (P = .001) in comparison to control group pati/ents at the study end point. There was a trend toward lower hospital readmission rates in the intervention group (16% vs 25%), but this was not statistically significant. Conclusion: This pilot study suggests that a full-scale trial of the HEART intervention is feasible.
No takes yet. Share an insight, caveat, or question.
Delaney et al. (2010) studied Heart failure (n=24). HEART intervention (nurse-directed multicomponent home care) vs. usual care and telemonitoring was evaluated on 90-day hospital readmission (p=not statistically significant). The HEART multicomponent home care intervention significantly improved quality of life (P=0.007) and reduced depressive symptoms (P=0.001), with 90-day readmission rates of 16% vs 25%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: